These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
652 related articles for article (PubMed ID: 35342303)
1. Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma. Chen X; Tu J; Ma L; Huang Y; Yang C; Yuan X Int J Gen Med; 2022; 15():3215-3235. PubMed ID: 35342303 [TBL] [Abstract][Full Text] [Related]
2. Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma. Wei SY; Feng B; Bi M; Guo HY; Ning SW; Cui R BMC Med Genomics; 2022 Dec; 15(1):263. PubMed ID: 36528763 [TBL] [Abstract][Full Text] [Related]
3. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma. Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889 [TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of a Ferroptosis-Related Long Non-Coding RNA (FRlncRNA) Signature to Predict Survival Outcomes and the Immune Microenvironment in Patients With Clear Cell Renal Cell Carcinoma. Zhou Z; Yang Z; Cui Y; Lu S; Huang Y; Che X; Yang L; Zhang Y Front Genet; 2022; 13():787884. PubMed ID: 35350243 [No Abstract] [Full Text] [Related]
5. Ferroptosis-Related Long Noncoding RNA Signature Predicts Prognosis of Clear Cell Renal Carcinoma. Liu JW; Supandi F; Dhillon SK Folia Biol (Praha); 2022; 68(1):1-15. PubMed ID: 36201853 [TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma. Ma X; Yu S; Zhao B; Bai W; Cui Y; Ni J; Lyu Q; Zhao J Front Immunol; 2022; 13():922315. PubMed ID: 35774794 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of N6-Methyladenosine-Related IncRNAs Prognostic Signature and the Associated Immune Infiltrates in Kidney Renal Clear Cell Carcinoma. Chen X; Wang L; Tu J; Pan X; Li Y; Yin H; Wang M; Yuan X Crit Rev Eukaryot Gene Expr; 2022; 32(1):79-98. PubMed ID: 35377983 [TBL] [Abstract][Full Text] [Related]
8. A Prognostic Signature for Clear Cell Renal Cell Carcinoma Based on Ferroptosis-Related lncRNAs and Immune Checkpoints. Dong Y; Liu D; Zhou H; Gao Y; Nueraihemaiti Y; Xu Y Front Genet; 2022; 13():912190. PubMed ID: 35685438 [No Abstract] [Full Text] [Related]
9. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma. Zhou L; Fang H; Guo F; Yin M; Long H; Weng G J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868 [TBL] [Abstract][Full Text] [Related]
10. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma. Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048 [TBL] [Abstract][Full Text] [Related]
11. Development and validation of ferroptosis-related lncRNA signature and immune-related gene signature for predicting the prognosis of cutaneous melanoma patients. Xiong K; Wang Z; Hounye AH; Peng L; Zhang J; Qi M Apoptosis; 2023 Jun; 28(5-6):840-859. PubMed ID: 36964478 [TBL] [Abstract][Full Text] [Related]
12. Construction and validation of a ferroptosis-related long noncoding RNA signature in clear cell renal cell carcinoma. Zhu Z; Zhang C; Qian J; Feng N; Zhu W; Wang Y; Gong Y; Li X; Lin J; Zhou L Cancer Cell Int; 2022 Sep; 22(1):283. PubMed ID: 36104748 [TBL] [Abstract][Full Text] [Related]
13. A Prognostic Ferroptosis-Related lncRNAs Signature Associated With Immune Landscape and Radiotherapy Response in Glioma. Zheng J; Zhou Z; Qiu Y; Wang M; Yu H; Wu Z; Wang X; Jiang X Front Cell Dev Biol; 2021; 9():675555. PubMed ID: 34095147 [TBL] [Abstract][Full Text] [Related]
14. Prognostication of Pancreatic Cancer Using The Cancer Genome Atlas Based Ferroptosis-Related Long Non-Coding RNAs. Li J; Zhang J; Tao S; Hong J; Zhang Y; Chen W Front Genet; 2022; 13():838021. PubMed ID: 35237306 [No Abstract] [Full Text] [Related]
15. Development and validation of a novel ferroptosis‑related lncRNA prognostic signature for pancreatic adenocarcinoma. Li J; Li W; Wang H; Ni B; Liu Y Mol Med Rep; 2023 Feb; 27(2):. PubMed ID: 36660936 [TBL] [Abstract][Full Text] [Related]
16. Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma. Ju L; Shi Y; Liu G PeerJ; 2022; 10():e14506. PubMed ID: 36570012 [TBL] [Abstract][Full Text] [Related]
17. Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification. Gao C; Kong N; Zhang F; Tang T; Li J; Ding H; Sun Z; Wu L; Xu M BMC Med Genomics; 2022 Jan; 15(1):15. PubMed ID: 35093068 [TBL] [Abstract][Full Text] [Related]
18. N6-Methyladenosine-Related Long Non-coding RNA Signature Associated With Prognosis and Immunotherapeutic Efficacy of Clear-Cell Renal Cell Carcinoma. Ma T; Wang X; Wang J; Liu X; Lai S; Zhang W; Meng L; Tian Z; Zhang Y Front Genet; 2021; 12():726369. PubMed ID: 34721523 [TBL] [Abstract][Full Text] [Related]
19. Identification and Validation of Ferroptosis-Related LncRNAs Signature as a Novel Prognostic Model for Chronic Lymphocytic Leukemia. Xu Z; Pan B; Li Y; Xia Y; Liang J; Kong Y; Zhang X; Tang J; Wang L; Li J; Xu W; Wu J Int J Gen Med; 2023; 16():1541-1553. PubMed ID: 37131869 [TBL] [Abstract][Full Text] [Related]
20. Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer. Wu Z; Lu Z; Li L; Ma M; Long F; Wu R; Huang L; Chou J; Yang K; Zhang Y; Li X; Hu G; Zhang Y; Lin C Front Immunol; 2021; 12():783362. PubMed ID: 35154072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]